KMB
31
3
BMY
33
-2
SRE
47
7
WU
16
4
MCD
57
5
JBHT
48
2
MTCH
57
2
PNR
60
3
QRVO
20
2
TMO
56
2
HCA
39
2
AIG
38
2
MA
64
2
NWSA
75
8
AKAM
53
5
FDX
36
3
AMZN
63
5
FE
37
3
TRV
42
5
SIG
55
3
KMB
31
3
BMY
33
-2
SRE
47
7
WU
16
4
MCD
57
5
JBHT
48
2
MTCH
57
2
PNR
60
3
QRVO
20
2
TMO
56
2
HCA
39
2
AIG
38
2
MA
64
2
NWSA
75
8
AKAM
53
5
FDX
36
3
AMZN
63
5
FE
37
3
TRV
42
5
SIG
55
3
Financhill
Back

Telefonica SA 10K Form

Sell
41

TEF
Telefonica SA

Last Price:
$4.04
Seasonality Move:
3.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TEF News And Ratings

See the #1 stock for the next 7 days that we like better than TEF

TEF Financial Statistics

Sales & Book Value

Annual Sales: $44B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $4.07
Price / Book: 0.99

Profitability

EPS (TTM): -0.28660
Net Income (TTM): $-1.2B
Gross Margin: $30.5B
Return on Equity: -4.27%
Return on Assets: -1.11%

Telefonica SA Earnings Forecast

Key Telefonica SA Financial Ratios

  • The Gross Profit Margin over the past 35 years for TEF is 69.26%.
  • The Selling, General & Administrative Expenses for TEF have been equal to 17.90% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -337.89% of Operating Income.
  • The Net Earning history of TEF is -2.19% of Total Revenues.
  • Per Share Earnings over the last 36 years have been positive in 20 years.

Telefonica SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Diversified Telecommunication Services
Sector: Communication Services
Current Symbol: TEF
CUSIP: 879382
Website: telefonica.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.85
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 20.82

TEF Technical Analysis vs Fundamental Analysis

Sell
41
Telefonica SA (TEF) is a Sell

Is Telefonica SA a Buy or a Sell?

  • Telefonica SA stock is rated a Sell
    The current Telefonica SA [TEF] share price is $4.04. The Score for TEF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.